Experts Mario Nuvolone, Vaishali Sanchorawala, and Patrick Hagen discuss the critical importance of early diagnosis in AL amyloidosis, ongoing clinical trials like Venetoclax and Exazomib, patient selection for SCT, and challenges in managing relapsed refractory amyloidosis.

Guests Angela Dispenzieri, MD, Paolo Lopedote, MD, and Vaishali Sanchorawala, MD discuss unmet needs in AL amyloidosis, including early diagnosis and optimal treatment strategies. They explore the prevalence and impact of CHIP in amyloidosis patients, as well as alternative treatment options for those who cannot undergo stem cell transplantation. The speakers also discuss refining hematologic response criteria and assessing residual disease in AL amyloidosis treatment.